1.6100
08-11月-24 14:03:24
15 分の遅延
株式
+0.0500
+3.21%
本日の幅
1.5500 - 1.6500
ISIN
N/A
ソース
NASDAQ
BioRestorative Therapies Announces it has Initiated its Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease – Site Selection Underway
07 2 2022 08:00:00 提供 Nasdaq GlobeNewswire
BioRestorative Therapies to Ring Nasdaq Stock Market Closing Bell
07 2 2022 06:45:00 提供 Nasdaq GlobeNewswire
BioRestorative Therapies Announces Notice of Allowance for New Patent Application in Japan and Expansion of ThermoStem® IP Portfolio
02 2 2022 07:00:01 提供 Nasdaq GlobeNewswire